Atopic dermatitis is one of the most common skin diseases. Since dermatologic products from natural raw materials are becoming increasingly popular, it is relevant to produce a semisolid transdermal preparation that would have not only natural active ingredients, but a natural base as well. A clinical study performed by Lee et al. (1) showed »the possible clinical use of rosmarinic acid (RA) as a therapeutic agent for atopic dermatitis«. Rosmarinic acid demonstrated cellular protective properties against the damaging radical species induced by UVB radiation (2) . Scientifi c literature describes penetration studies with RA using Caco-2 cell monolayers (3), which refl ects penetration of RA through the intestinal wall. Research has shown (3) that the botanical matrix had no eff ect on RA penetration through the Caco-2 cell monolayer. Lee et al. (1) performed a clinical study to evaluate the eff ect of a topical RA preparation. However, in our review of scientifi c literature, we failed to fi nd any studies analyzing the penetration of RA through undamaged fullthickness human skin.
RA is the key active ingredient of a Melissa offi cinalis L. extract (4) . European Pharmacopoeia, monograph Melissa offi cinalis L. leaves, states that Melissa offi cinalis L. leaves should contain at least 4 % of hydroxycinnamic acids expressed as RA. RA is also known as an antiviral (5), anti-infl ammatory (5), antioxidant (6), photoprotective (2) and anti-proliferative (6) component of Melissa offi cinalis L., which makes it relevant to apply the Melissa offi cinalis L. extract as a natural source of RA in the modeling of semisolid formulations.
The aim of this study was to evaluate the release of rosmarinic acid from the experimental topical formulations with the Melissa offi cinalis L. extract and to evaluate its penetration through undamaged human skin ex vivo.
EXPERIMENTAL

Materials
Rosmarinic acid, HPLC-grade acetonitrile, and acetic acid were purchased from Sigma Aldrich Chemie GmBH (Germany). Standardized dry lemon balm extract (sicc. Extractum Melissae offi cinalis) was purchased from Naturex (France).
Methods
Preparation of semisolid formulations. -The components of the formulation are listed in Table I . The choice of the components for the ointment and w/o cream semisolid vehicles were developed with reference to the earlier published research data (7) . In accordance with the study of Lee et al. (1) , the formulations were produced with 4 % of dry lemon balm extract containing 80 mg g -1 RA. Formulations were prepared according to the general technological principles of semisolid preparation.
Quantifi cation of rosmarinic acid by HPLC. -The amount of RA was evaluated by applying the capillary HPLC method, which was developed and validated, using the Agilent 1260 Infi nity Capillary LC System (Agilent Technologies, USA) with an Agilent diode array detector. The separation was performed on a C18 ACE (5 µm) 150x0.5 mm i.d. column. The , with the detection wavelength set at 330 nm.
Rheological fl ow behavior test. -The test (n = 5) was performed using the Carri-med CSL 2 500 rheometer (TA Instruments, Germany), applying the cone-and-plate geometry system (cone diameter 60 mm, angle 2 o , sample thickness 150 µm). The shear rate was increased from 0 to 500 s -1 for 2 minutes. The rheological properties of the samples were determined according to the Oswald de Waele (8) which is the indicator of viscosity. The fl ow behavior index (n) is a dimensionless number that indicates the closeness to the Newtonian fl ow. For a Newtonian liquid n = 1 for a dilatant fl uid n > 1, and for a pseudoplastic fl uid n < 1 (8) .
In vitro release study. -In vitro release experiments were performed using modifi ed Franz-type diff usion cells (9) . The semisolid sample (1.00 ± 0.02 g) was placed into the cell with a dialysis membrane Cuprophan ® (Medicell International Ltd., UK). The area of the diff usion was 1.77 cm 2 . Thermostated (37 ± 0.2 o C) purifi ed water acted as the acceptor medium. The medium was stirred using a magnetic stirrer. Samples from the acceptor solution were taken at 1, 2, 4, and 6 h and were immediately replaced with the same volume of fresh acceptor solution.
Ex vivo penetration through the full-thickness undamaged human skin. -Abdominal skin of Caucasian women (age range 25-40 years) was obtained from the Department of Plastic and Reconstructive Surgery (the Hospital of the Lithuanian University of Health Sciences, Lithuania) a er cosmetic surgery. It was stored at -20 °C for not longer than 6 months before use. Kaunas Regional Biomedical Research Ethics Commi ee had approved the use of human skin for transdermal penetration studies. A Bronaugh-type fl ow-through diff usion cell with full-thickness human skin was used for ex vivo skin penetration experiments (n = 3). The experiment was performed according to the methods proposed by Kezutyte et al. and Zilius et al. (9, 10) .
Statistical data evaluation was performed using the SPSS so ware with one-way ANOVA. Tukey's post hoc test was performed for multiple comparisons.
RESULTS AND DISCUSSION
Stable vehicles were developed in our previous research (7) . Vehicles contained all components indicated in Table I , except Melissa offi cinalis L. extract. Formulation N1 was a hydrophobic vehicle with solid paraffi n and vaseline, formulation N2 a hydrophobic vehicle with beeswax instead of paraffi n and honey instead of vaseline, formulation N3 was an emulsion vehicle with dry Melissa offi cinalis L. extract, and formulation N4 was an emulsion vehicle with aqueous Melissa offi cinalis L. extract. During the fi rst stage of the study, we evaluated the infl uence of the semisolid bases and the addition of the extract on the rheological characteristics of the formulations by determining their consistency index and fl ow behavior index. Modifi cation of viscosity is an important part of the preparation of semisolid formulations and is regarded to be a critical quality a ribute in the development stage of the product (11) . To evaluate the possible eff ect of temperature on the structure of semisolid formulations during their storage period, we selected the temperature of 30 o C, which was approximate to the melting temperature of the experimental formulations as well as to the skin surface temperature. The obtained results showed that all the investigated formulations displayed pseudoplastic characteristics. The results of the experiments showed that addition of the Melissa offi cinalis L. extract signifi cantly reduced consistency indices of the formulations and increased their fl ow behavior indices compared to the rheological characteristics of the vehicles (Fig. 1 ).
The addition of dry Melissa offi cinalis L. extract had the greatest infl uence on the rheological properties of N3 as compared to those of hydrophobic formulations (N1 and N2). The results showed that the addition of the active substance in its dry form had a greater impact on the rheological properties of emulsion formulations. The calculated consistency and fl ow behavior indices refl ected the eff ect of the Melissa offi cinalis L. extract on the weakening of the structure of semisolid formulations, which may aff ect the expiry date of formulations.
The results of the RA release studies were in line with the published data, demonstrating that the release of drug substances from semisolid vehicles is infl uenced not only by the properties of the drug molecule, but also by the properties of the vehicle (12) . Data presented in Fig. 2 show that higher amounts of RA were released from the vehicles (N1, N2, and N3) when the Melissa offi cinalis L. extract was added in its dry form compared to formulation N4, which contained an aqueous lemon-balm extract. The results of the experiments demonstrated that formulation N4 released the lowest amounts (less than 1 %) of RA (Fig. 2 ) within 6 hours of testing. Hypothetically, it can be stated that the diff usion of RA from the aqueous phase of this emulsion was hampered by the inner lipophilic phase. The highest amounts (39.6 %) of RA were released from the emulsion vehicle N3 within 6 hours. Results of the statistical analysis revealed a statistically signifi cant (p < 0.01) inverse correlation (Spearman's correlation coeffi cient of -0.82) between the consistency index and the amount of RA released from the formulations within 6 hours of the experiment. However, no statistically signifi cant diff erences between N1, N2 or N4 were found. A statistically signifi cant (p < 0.05) diff erence of RA release from N3 could be determined by the consistency index, which was signifi cantly (p < 0.05) diff erent from that of the emulsion base. Since the consistency index indicates viscosity (8) , and viscosity, in turn, has an inversely proportional infl uence on the diff usion process, a decrease in viscosity could lead to an increase in the substance release rate.
Penetration of RA from the aqueous Melissa offi cinalis L. extract through the skin was infl uenced only by the diff usion process and the properties of the active substance itself. It was therefore, used as a penetration reference. Penetration tests through undamaged human skin within 24 hours revealed that the aqueous Melissa offi cinalis L. extract penetrated the epidermis and the dermis; unfortunately, the amounts traced in the dermis could not be assessed quantitatively. The results confi rmed the data presented in the literature, indicating that passive diff usion of a solute from its vehicle into the skin is determined by the unique molecular and physical properties of the diff usant, the vehicle and the skin (13) .
The results of the study showed that RA from hydrophobic formulations N1 and N2 penetrated the epidermis within 24 hours of the experiment (Table II) , and the amount penetrated (0.20 % and 0.15 %, respectively) was half that of RA from the reference. No RA was found in the dermis. The obtained results also showed that the penetration of RA was limited by the release of the active substance from the dosage form. It should be noted that hydrophobic formulations contain 15 % of substances that form a fi lm on the surface of the skin (beeswax, paraffi n, or petroleum jelly) (14) , which may constitute an additional barrier to RA. RA that penetrated from N4 was also traced only in the epidermis (0.22 %). The results of the statistical analysis revealed that there was no statistically signifi cant diff erence in the amounts of RA that penetrated the epidermis from formulations N1, N2, and N4. The results of the experiments demonstrated that the penetration of RA from formulation N3 into the epidermis was approximately 6-fold higher (1.08 %) compared to the results a er the application of N1, N2 and N4. The quantities of RA were signifi cantly higher in the epidermis when emulsion N3 was used as a vehicle for RA if compared to the application of the reference. The results of the penetration assessment showed that RA was accumulating in the epidermis, and the hydrophilic dermis acted as a barrier preventing deeper penetration and entry of RA into systemic blood fl ow. Data showed that the penetration of RA from N3 was enhanced because the penetration was greater than the refer- ence. The enhancer was probably olive oil, which was one of the components of the vehicle. Olive oil contains high amounts of oleic acid, which is known as a penetration enhancer (15) . RA was not found in the acceptor phase of any sample. These results have show that RA used topically generates only local eff ects.
CONCLUSIONS
The results of the in vitro release study showed that higher amounts of RA were released from the emulsion vehicle when the Melissa offi cinalis L. extract was added in its dry form. An inverse correlation was detected between the amount of RA released and the consistency index of the vehicle, the decreasing viscosity of the formulations resulting in higher amounts of RA being released. Diff erences in penetration of RA into the skin may be infl uenced by the characteristics of the vehicle as well as by the form of the extract. The results have shown that RA used topically generates only local eff ects. Further studies are required for the development of more eff ective lemon balm extract-containing formulations that would ensure a be er penetration of RA into the skin. 
